Clinical trial
Rosiglitazone and Insulin Resistance in Renally Impaired Patients
NCT00452166 · Leiden University Medical Center, Other · Terminated
Key facts
| NCT number | NCT00452166 |
|---|---|
| Title | Rosiglitazone and Insulin Resistance in Renally Impaired Patients |
| Official title | Rosiglitazone and Insulin Resistance in Renally Impaired Patients |
| Lead sponsor | Leiden University Medical Center, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, Insulin Resistance |
| Intervention type | Drug |
| Interventions | rosiglitazone |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 27, 2007 |
| Last update posted | Oct 2, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: